About the study: The BioImage study, which is part of the HRP initiativemanaged by BG Medicine, seeks to accurately identify people who may be at ahigher risk for heart attack within three years after they begin participatingin the BioImage research trial. The potential study participants aremedium- to high-risk individuals with no prior history of cardiovasculardisease.
The majority of heart attacks are due to what is known as "vulnerable"plaque, small areas of soft plaque in arteries, which can rupture and lead toa blood clot, resulting in a stroke or heart attack.
Conventional medical tests are not capable of detecting this dangerouskind of plaque. Although treatments using existing drugs or new drugs indevelopment are likely to be very effective, no treatment is possible untilone can reliably find individuals before their first event. Coronary heartdisease is America's No. 1 killer and stroke is the third-leading cause ofdeath.
Approximately 49,000 South Florida Humana members between the ages of 55and 80 will be notified that they are eligible to volunteer for this importantstudy. The goal is to recruit and enroll up to 5,300 individuals in theBioImage study over a nine-month period.
For more on the BioImage study, visit the Web site atwww.bioimagestudy.com.
* Digital photographs of the BioImage clinic, Don Shula and Willy Chirinoare available upon request.Unprecedented medical research study aims to find novel means to identify people at risk for heart attacks What: Humana, Florida's largest Medicare health benefits company with nearly half a million members statewide, and BG Medicine, are hosting a launch event Wed., Nov. 19 to mark the start of a three-year landmark medical research study to develop new blood or imaging tests to identify people at high risk for a first heart attack or stroke. The BioImage study, which is open to selected Humana South Florida health plan members, may hold the key to new means to prevent first cardiovascular events (more about the study below). Political, community and medical leaders attending the Nov. 19 launch will see firsthand the state-of-the-art imaging techniques utilized in the study; have the opportunity to tour the mobile unit and clinic as participants; and, experience the BioImage study investigations. Who: Hall of Fame football coach Don Shula GRAMMY Award-winning singer and Humana Florida Hispanic market spokesman Willy Chirino BG Medicine President and CEO Dr. Peter Muntendam Humana Vice President of Research and Development Carol McCall When: Wed., Nov. 19, 2008 10 a.m. - noon Where: BioImage Clinic (Old North Ridge Medical Center) 5757 N Dixie Highway Oakland Park, FL 33334
SOURCE Humana Inc.